423 related articles for article (PubMed ID: 14724822)
1. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].
Hui JM; Sud A; Farrell GC; Bandara P; Byth K; Kench JG; McCaughan GW; George J
Gastroenterology; 2003 Dec; 125(6):1695-704. PubMed ID: 14724822
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in chronic hepatitis B virus infection.
Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK
Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853
[TBL] [Abstract][Full Text] [Related]
4. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
Cua IH; Hui JM; Kench JG; George J
Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in chronic hepatitis B and C.
Mohammad Alizadeh AH; Fallahian F; Alavian SM; Ranjbar M; Hedayati M; Rahimi F; Khedmat H; Etemadi A; Zali MR; Azizi F
Indian J Gastroenterol; 2006; 25(6):286-9. PubMed ID: 17264427
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
10. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin and homeostasis model assessment-IR as novel predictors of early liver fibrosis in chronic hepatitis B virus infection.
Mousa N; Abdel-Razik A; Sheta T; Shabana W; Zakaria S; Awad M; Abd Elsalam M; El-Wakeel N; Elkashef W; Effat N; Elgamal A; Deiab AG; Eldars W
Br J Biomed Sci; 2018 Oct; 75(4):192-196. PubMed ID: 30079841
[TBL] [Abstract][Full Text] [Related]
12. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
Patel K; Thompson AJ; Chuang WL; Lee CM; Peng CY; Shanmuganathan G; Thongsawat S; Tanwandee T; Mahachai V; Pramoolsinsap C; Cho M; Han KH; Shah SR; Foster GR; Clark PJ; Pulkstenis E; Subramanian GM; McHutchison JG
J Gastroenterol Hepatol; 2011 Jul; 26(7):1182-8. PubMed ID: 21410752
[TBL] [Abstract][Full Text] [Related]
15. Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
Jian Wu Y; Shu Chen L; Gui Qiang W
Liver Int; 2006 Mar; 26(2):166-72. PubMed ID: 16448454
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
18. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
Hui JM; Kench J; Farrell GC; Lin R; Samarasinghe D; Liddle C; Byth K; George J
J Gastroenterol Hepatol; 2002 Aug; 17(8):873-81. PubMed ID: 12164963
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.
Wójcik K; Jabłonowska E; Omulecka A; Piekarska A
World J Gastroenterol; 2014 Aug; 20(30):10449-56. PubMed ID: 25132761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
